These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 28181054

  • 1. An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer.
    Panebianco V, De Berardinis E, Barchetti G, Simone G, Leonardo C, Grompone MD, Del Monte M, Carano D, Gallucci M, Catto J, Catalano C.
    Eur Radiol; 2017 Sep; 27(9):3759-3766. PubMed ID: 28181054
    [Abstract] [Full Text] [Related]

  • 2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G, Sciarra A, Leonardo C, Gallucci M, Catalano C, Catto JWF, Panebianco V.
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [Abstract] [Full Text] [Related]

  • 3. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
    Arita Y, Kwee TC, Woo S, Shigeta K, Ishii R, Okawara N, Edo H, Waseda Y, Vargas HA.
    Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790
    [Abstract] [Full Text] [Related]

  • 4. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G, Simone G, Ceravolo I, Salvo V, Campa R, Del Giudice F, De Berardinis E, Buccilli D, Catalano C, Gallucci M, Catto JWF, Panebianco V.
    Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
    [Abstract] [Full Text] [Related]

  • 5. Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.
    Wang F, Chen HG, Zhang RY, Jin D, Xu SS, Wu GY, Xu JR.
    Eur Radiol; 2019 Aug; 29(8):4447-4455. PubMed ID: 30666451
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a fractional-order calculus diffusion model and bi-parametric VI-RADS for staging and grading bladder urothelial carcinoma.
    Feng C, Wang Y, Dan G, Zhong Z, Karaman MM, Li Z, Hu D, Zhou XJ.
    Eur Radiol; 2022 Feb; 32(2):890-900. PubMed ID: 34342693
    [Abstract] [Full Text] [Related]

  • 7. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L, Wen Z, Cai Q, Lin Y, Chen Y, Cao W, Li M, Qian L, Chen J, Guo Y, Wang H.
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [Abstract] [Full Text] [Related]

  • 8. Value of multiparametric magnetic resonance imaging for local staging of invasive urinary bladder tumours.
    Huele EH, Veenboer PW, Wessels FJ, Jonges TN, Meijer RP.
    Urol Oncol; 2023 Jan; 41(1):49.e7-49.e12. PubMed ID: 36441069
    [Abstract] [Full Text] [Related]

  • 9. Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
    Wang F, Wu LM, Hua XL, Zhao ZZ, Chen XX, Xu JR.
    J Magn Reson Imaging; 2018 Apr; 47(4):1054-1060. PubMed ID: 28815808
    [Abstract] [Full Text] [Related]

  • 10. Role of Additional MRI-Based Morphologic Measurements on the Performance of VI-RADS for Muscle-Invasive Bladder Cancer.
    Gong Y, Cheng Y, Zhang J, Bao ML, Zhu FP, Sun XY, Zhang YD.
    J Magn Reson Imaging; 2024 Sep; 60(3):1113-1123. PubMed ID: 38258496
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of amide proton transfer imaging for bladder cancer histopathologic features: A comparative study with diffusion- weighted imaging.
    Wang F, Xiang YS, Wu P, Shen AJ, Wang PJ.
    Eur J Radiol; 2023 Feb; 159():110664. PubMed ID: 36574743
    [Abstract] [Full Text] [Related]

  • 12. Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
    Hong SB, Lee NK, Kim S, Son IW, Ha HK, Ku JY, Kim KH, Park WY.
    J Magn Reson Imaging; 2020 Oct; 52(4):1249-1256. PubMed ID: 32220105
    [Abstract] [Full Text] [Related]

  • 13. Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.
    Bryan RT, Liu W, Pirrie SJ, Amir R, Gallagher J, Hughes AI, Jefferson KP, Knight A, Nanton V, Mintz HP, Pope AM, Catto JWF, Patel P, James ND.
    Eur Urol; 2021 Jul; 80(1):12-15. PubMed ID: 33653635
    [Abstract] [Full Text] [Related]

  • 14. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.
    Wang HJ, Pui MH, Guo Y, Li SR, Guan J, Zhang XL, Cai HS.
    AJR Am J Roentgenol; 2015 Feb; 204(2):330-4. PubMed ID: 25615755
    [Abstract] [Full Text] [Related]

  • 15. Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
    Gmeiner J, Garstka N, Helbich TH, Shariat SF, Baltzer PA.
    Eur J Radiol; 2021 Sep; 142():109829. PubMed ID: 34252867
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of Muscular Invasion in Bladder Cancer: Additional Value of Synthetic Magnetic Resonance Imaging.
    Zhang X, Guo J, Yun Y, Shan D, Yang D, Xu C, Chen X.
    Acad Radiol; 2024 Oct; 31(10):4076-4084. PubMed ID: 38548534
    [Abstract] [Full Text] [Related]

  • 17. Prediction of muscle invasion of bladder cancer: A comparison between DKI and conventional DWI.
    Li Q, Cao B, Tan Q, Liu K, Jiang S, Zhou J.
    Eur J Radiol; 2021 Mar; 136():109522. PubMed ID: 33434860
    [Abstract] [Full Text] [Related]

  • 18. Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
    Arita Y, Shigeta K, Akita H, Suzuki T, Kufukihara R, Kwee TC, Ishii R, Mikami S, Okuda S, Kikuchi E, Oya M, Jinzaki M.
    Eur Radiol; 2021 Feb; 31(2):875-883. PubMed ID: 32829418
    [Abstract] [Full Text] [Related]

  • 19. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer.
    Yoshida S, Koga F, Kawakami S, Ishii C, Tanaka H, Numao N, Sakai Y, Saito K, Masuda H, Fujii Y, Kihara K.
    Urology; 2010 Feb; 75(2):387-91. PubMed ID: 19914691
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness.
    Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H, Komai Y, Yokoyama M, Saito K, Fujii Y, Kawakami S, Kihara K.
    Eur Radiol; 2011 Oct; 21(10):2178-86. PubMed ID: 21688007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.